Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Node Biopsy and Targeted Axillary Dissection in Node-Positive Breast Cancer Patients With Clinically Negative Axilla

NCT04671511 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT04671511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04671511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Node Biopsy and Targeted Axillary Dissection in Node-Positive Breast Cancer Patients With Clinically Negative Axilla
Lead sponsor
Jewish General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2021
Completion date
July 31, 2026
Enrollment
98 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

axillary metastases, breast cancer female, early-stage breast cancer, lymph node metastases, sentinel lymph node